Comorbidity: What have we learned and where are we going?

Clinical Psychology: Science and Practice

Volumn 14, Issue 1, 2007, Pages 64-69

  Mueser, Kim T ^a,b   Drake, Robert E ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

Author keywords

Co occurring disorder; Comorbidity; Dualdisorder; Schizophrenia; Severemental illness; Substance abuse

Indexed keywords

NEUROLEPTIC AGENT;

CANNABIS ADDICTION; COMORBIDITY; CORONARY ARTERY DISEASE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; GENETIC RISK; HEALTH HAZARD; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNTINGTON CHOREA; MENTAL DISEASE; MOTIVATION; NOTE; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE; SYMPTOM; UNSPECIFIED SIDE EFFECT;

EID: 33847663312     PISSN: 09695893     EISSN: 14682850     Source Type: Journal    
DOI: 10.1111/j.1468-2850.2007.00063.x     Document Type: Note

References (53)

1. Abikoff, H., & Klein, R. G. (1992). Attention-deficit hyperactivity and conduct disorder: Comorbidity and implications for treatment. Journal of Consulting and Clinical Psychology, 60, 881-892.
2. Alterman, A. I., & Cacciola, J. S. (1991). The antisocial personality disorder diagnosis in substance abusers: Problems and issues. Journal of Nervous and Mental Disease, 179, 167-175.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4. Ananth, J., Vandewater, S., Kamal, M., Brodsky, A., Gamal, R., & Miller, M. (1989). Missed diagnosis of substance abuse in psychiatric patients. Hospital and Community Psychiatry, 40, 297-299.
5. Arseneault, L., Cannon, M., Witton, J., & Murray, R. M. (2004). Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry, 184, 110-117.
6. Bartels, S. J., Forester, B., Mueser, K. T., Miles, K. M., Dums, A. R., Pratt, S. I., et al. (2004). Enhanced skills training and health care management for older persons with severe mental illness. Community Mental Health Journal, 40, 75-90.
7. Bellack, A. S., Bennet, M. E., Gearon, J. S., Brown, C. H., & Yang, Y. (2006). A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Archives of General Psychiatry, 63, 426-432.
8. Brown, T. A., & Barlow, D. H. (1992). Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. Journal of Consulting and Clinical Psychology, 60, 835-844.
9. Brunette, M. F., Mueser, K. T., & Drake, R. E. (2004). A review of research on residential programs for people with severe mental illness and co-occurring substance use disorders. Drug and Alcohol Review, 23, 471-481.
10. Carey, K. B., Leontieva, L., Dimmock, J., Maisto, S. A., & Batki, S. L. (2007). Adapting motivational interventions for comorbid schizophrenia and alcohol use disorders. Clinical Psychology: Science and Practice, 14, 39-57.
11. Caspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., et al. (2005). Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: Longitudinal evidence of a gene X environment interaction. Biological Psychiatry, 57, 1117-1127.
12. Center for Disease Control. (2001). HIV/AIDS surveillance report. Atlanta, GA: Department of Health and Human Services.
13. Clarkin, J. F., & Kendall, P. C. (1992). Comorbidity and treatment planning: Summary and future directions. Journal of Consulting and Clinical Psychology, 60, 904-908.
14. Covell, N. H., Jackson, C. T., Evans, A. C., & Essock, S. M. (2002). Antipsychotic prescribing practices in Connecticut's public mental health system: Rates of changing medications and prescribing styles. Schizophrenia Bulletin, 28, 17-29.
15. Dalmau, A., Bergman, B., & Brismar, B. (1997). Somatic morbidity in schizophrenia: A case control study. Public Health, 111, 393-397.
16. Dixon, L., McNary, S., & Lehman, A. (1995). Substance abuse and family relationships of persons with severe mental illness. American Journal of Psychiatry, 152, 456-458.
17. Dixon, L., Postrado, L., Delahanty, J., Fischer, P. J., & Lehman, A. (1999). The association of medical comorbidity in schizophrenia with poor physical and mental health. The Journal of Nervous and Mental Disease, 187, 496-502.
18. Donald, M., Dower, J., & Kavanagh, D. J. (2005). Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: A qualitative systematic review of randomised controlled trials. Social Science & Medicine, 60, 1371-1383.
19. Drake, R. E. (in press). Psychosocial intervention research on co-occurring disorders. Journal of Dual Diagnosis.
20. Drake, R. E., & Brunette, M. F. (1998). Complications of severe mental illness related to alcohol and other drug use disorders. In M. Galanter (Ed.), Recent developments in alcoholism: Consequences of alcoholism (Vol. 14, pp. 285-299). New York: Plenum Publishing Company.
21. Drake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004). A review of treatments for clients with severe mental illness and co-occurring substance use disorder. Psychiatric Rehabilitation Journal, 27, 360-374.
22. Drake, R. E., Osher, F. C., & Wallach, M. A. (1991). Homelessness and dual diagnosis. American Psychologist, 46, 1149-1158.
23. Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards, V., et.al. (1998). Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Event (ACE) study. American Journal of Preventive Medicine, 14, 245-258.
24. Felker, B., Yazel, J., & Short, D. (1996). Mortality and medical comorbidity among psychiatric patients: A review. Psychiatric Services, 47, 1356-1362.
25. Hinshaw, S. P. (1992). Academic underachievement, attention deficits, and aggression: Comorbidity and implications for intervention. Journal of Consulting and Clinical Psychology, 60, 893-903.
26. Hser, Y. I., Hoffman, V., Grella, C. E., & Anglin, D. (2001). A 33-year follow-up of narcotics addicts. Archives of General Psychiatry, 58, 503-508.
27. Johnson, D. R., Fontana, A., Lubin, H., Corn, B., & Rosenheck, R. (2004). Long-term course of treatment-seeking Vietnam veterans with posttraumatic stress disorder: Mortality, clinical condition, and life satisfaction. Journal of Nervous and Mental Disease, 192, 35-41.
28. Kavanagh, D. J., Waghorn, G., Jenner, L., Chant, D. C., Carr, V., Evans, M., et al. (2004). Demographic and clinical correlates of comorbid substance use disorders in psychosis: Multivariate analyses from an epidemiological sample. Schizophrenia Research, 66, 115-124.
29. Kendall, P. C., & Clarkin, J. F. (1992). Introduction to special section: Comorbidity and treatment implications. Journal of Consulting and Clinical Psychology, 60, 833-834.
30. Kendall, P. C., Kortlander, E., Chansky, T. E., & Brady, E. U. (1992). Comorbidity of anxiety and depression in youth: Treatment implications. Journal of Consulting and Clinical Psychology, 60, 869-880.
31. Kessler, R. C., Nelson, C. B., McGonagle, K. A., Edlund, M. J., Frank, R. G., & Leaf, P. J. (1996). The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry, 66, 17-31.
32. de Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135-157.
33. Meade, C. S., & Weiss, R. D. (2007). Substance abuse as a risk factor for HIV sexual risk behavior among persons with severe mental illness: Review of evidence and exploration of mechanisms. Clinical Psychology: Science and Practice, 14, 23-33.
34. Meyer, R. E. (1986). How to understand the relationship between psychopathology and addictive disorders: Another example of the chicken and the egg. In R. E. Meyer (Ed.), Psychopathology and addictive disorders (pp. 3-16). New York: Guilford Press.
35. Mueser, K., Bellack, A., & Blanchard, J. (1992). Comorbidity of schizophrenia and substance abuse. Journal of Consulting and Clinical Psychology, 60, 845-856.
36. Mueser, K. T., Crocker, A. G., Frisman, L. B., Drake, R. E., Covell, N. H., & Essock, S. M. (2006). Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders. Schizophrenia Bulletin, 32, 626-636.
37. Mueser, K. T., Drake, R. E., & Bond, G. R. (1997). Recent advances in psychiatric rehabilitation for patients with severe mental illness. Harvard Review of Psychiatry, 5, 123-137.
38. Mueser, K. T., Drake, R. E., Sigmon, S. C., & Brunette, M. F. (2005). Psychosocial interventions for adults with severe mental illnesses and co-occurring substance use disorders: A review of specific interventions. Journal of Dual Diagnosis, 1, 57-82.
39. Mueser, K., Drake, R., & Wallach, M. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23, 717-734.
40. Mueser, K. T., Noordsy, D. L., Drake, R. E., & Fox, L. (2003). Integrated treatment for dual disorders: A guide to effective practice. New York: Guilford Press.
41. Mueser, K. T., Yarnold, P. R., Rosenberg, S. D., Swett, C., Miles, K. M., & Hill, D. (2000). Substance use disorder in hospitalized severely mentally ill psychiatric patients: Prevalence, correlates, and subgroups. Schizophrenia Bulletin, 26, 179-192.
42. Piotrowski, N. A. (2007). Comorbidity and psychological science: Does one size fit all? Clinical Psychology: Science and Practice, 14, 6-19.
43. President's New Freedom Commission on Mental Health. (2003). Achieving the promise: Transforming mental health care in America. Final report. DHHS Pub. No. SMA-03-3832. Rockville, MD: Substance Abuse and Mental Health Services Administration.
44. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., et al. (1990). Comorbidity of mental disorders with alcohol and other drug abuse: Results from the Epidemiologic Catchment Area (ECA) study. Journal of the American Medical Association, 264, 2511-2518.
45. Ridgely, M. S., Goldman, H. H., & Talbott, J. A. (1986). Chronically mentally ill young adults with substance abuse problems: A review of the literature and creation of a research agenda. Baltimore, MD: University of Maryland Mental Health Policy Studies Center.
46. Ridgely, M. S., Goldman, H. H., & Willenbring, M. (1990). Barriers to the care of persons with dual diagnoses: Organizational and financing issues. Schizophrenia Bulletin, 16, 123-132.
47. Rosenberg, S. D., Brunette, M. F., Oxman, T., Marsh, B., Dietrich, A., Mueser, K. T., et.al. (2004). The STIRR model of best practices for blood-borne diseases among clients with serious mental illness. Psychiatric Services, 55, 660-664.
48. Rosenberg, S. D., Goodman, L. A., Osher, F. C., Swartz, M., Essock, S. M., Butterfield, M. I., et al. (2001). Prevalence of HIV, hepatitis B and hepatitis C in people with severe mental illness. American Journal of Public Health, 91, 31-37.
49. Shea, M. T., Widiger, T. A., & Klein, M. H. (1992). Comorbidity of personality disorders and depression: Implications for treatment. Journal of Consulting and Clinical Psychology, 60, 857-868.
50. Teeson, M., Hall, W., Lynskey, M., & Degenhardt, L. (2000). Alcohol and drug use disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry, 34, 206-213.
51. Tsemberis, S., Gulcur, L., & Nakae, M. (2004). Housing first, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. American Journal of Public Health, 94, 651-656.
52. Vaillant, G. E. (1995). Natural history of alcoholism revisited. Cambridge, MA: Harvard University Press.
53. Waddington, J. L., Youssef, H. F., & Kinsella, A. (1998). Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study. British Journal of Psychiatry, 173, 325-329.